Boardroom Alpha
Boardroom Alpha
CE · Current Report (Form 8-K) · Filed December 17, 2025

Celanese Corp — Current Report (Form 8-K)

Form
8-K
Filed
December 17, 2025
Period
Dec 17, 2025
Ticker
CE
Accession
0001628280-25-057638
Boardroom Alpha · Filing insights

Celanese US completes issuance of $1.4B senior notes due 2031 and 2034; proceeds to repay debt and fund tender offers.

About Celanese Corp
Market cap
$6.1B
1Y TSR
+4.4%
3Y TSR
−19.1%
Board grade
C
Sector
Basic Materials
CEO
Scott A Richardson
Last annual meeting: Apr 16, 2026 · View full Celanese Corp profile →
ce-20251217

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 17, 2025 (December 17, 2025)
CELANESE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3241098-0420726
   
(State or other jurisdiction
of incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (972) 443-4000
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange
4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange
2.125% Senior Notes due 2027CE /27The New York Stock Exchange
0.625% Senior Notes due 2028CE /28The New York Stock Exchange
5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange
5.000% Senior Notes due 2031
CE /31
The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
1


Item 1.01 Entry into a Material Definitive Agreement.
Completion of Offering of Senior Notes by Celanese US Holdings LLC
On December 17, 2025, Celanese US Holdings LLC ("Celanese US" or the "Issuer"), a wholly owned subsidiary of Celanese Corporation (the "Company"), completed its registered offering of $600,000,000 aggregate principal amount of its 7.000% Senior Notes due 2031 (the "2031 Notes") and $800,000,000 aggregate principal amount of its 7.375% Senior Notes due 2034 (the "2034 Notes" and together with the 2031 Notes, the "Notes"). The Notes have been issued under an Indenture, dated as of May 6, 2011 (the "Base Indenture"), among the Company, Celanese US, and Computershare Trust Company, N.A. (as successor trustee to Wells Fargo Bank, National Association), as trustee (the "Base Trustee"), as amended by the Seventeenth Supplemental Indenture, dated December 17, 2025 (the "Seventeenth Supplemental Indenture"), among the Company, Celanese US, certain subsidiaries of Celanese US (the "Subsidiary Guarantors"), U.S. Bank Trust Company, National Association, as series trustee, and the Base Trustee.
The net proceeds from the sale of the Notes, together with available cash, will be used (i) to repay the outstanding borrowings under the Company's five-year term loan credit agreement due 2027, (ii) to fund the previously-announced and upsized tender offers to purchase for cash approximately $1.2 billion aggregate principal amount of the Issuer's outstanding 6.665% Senior Notes due 2027 and outstanding 6.850% Senior Notes due 2028 and (iii) for general corporate purposes, which may include the repayment of other outstanding indebtedness.
The Issuer's obligations under the Notes are guaranteed on a senior unsecured basis by the Company and, initially, by the Subsidiary Guarantors. The Notes pay interest semi-annually, in arrears, on February 15 and August 15 of each year, beginning on August 15, 2026.
The offering of the Notes was registered under the Securities Act of 1933, as amended, and was made pursuant to the Registration Statement on Form S-3, Reg. No. 333-271048, and the prospectus included therein, filed by the Company with the Securities and Exchange Commission (the "Commission") on March 31, 2023, the related prospectus supplement filed with the Commission on December 5, 2025, and the free writing prospectus filed with the Commission on December 3, 2025.
The foregoing description does not constitute a complete summary of the terms of the Notes, the Base Indenture and the Seventeenth Supplemental Indenture and is qualified in its entirety by reference to the copies of the form of Notes, the Seventeenth Supplemental Indenture and the Base Indenture filed as Exhibits 4.1, 4.2 and 4.3, respectively, to this Current Report, which are each incorporated herein by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information included in Item 1.01 of this Current Report is incorporated by reference into this Item 2.03.
2


Item 9.01 Financial Statements and Exhibits.
(d)Exhibits
Exhibit NumberDescription
4.1*
4.2*
4.3
5.1*
23.1*
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101).
__________________
*Filed herewith.
3


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CELANESE CORPORATION 
By:
/s/ ASHLEY B. DUFFIE
Name: Ashley B. Duffie
Title: Senior Vice President, General Counsel and Corporate Secretary
Date:
December 17, 2025
4
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Celanese Corp (CE)

Reference

Frequently asked questions

When did Celanese Corp file this 8-K?
Celanese Corp (CE) filed this Current Report (Form 8-K) with the SEC on December 17, 2025. The accession number assigned by EDGAR is 0001628280-25-057638.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Celanese US completes issuance of $1.4B senior notes due 2031 and 2034; proceeds to repay debt and fund tender offers. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Celanese Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Celanese Corp has filed under CIK 1306830, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer